Filing Details

Accession Number:
0001179110-15-010186
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-23 16:00:05
Reporting Period:
2015-06-19
Filing Date:
2015-06-23
Accepted Time:
2015-06-23 16:00:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1121702 Metabolix Inc. MBLX Miscellaneous Plastics Products (3080) 043158289
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1377832 Matthew Strobeck C/O Metabolix, Inc.
21 Erie Street
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-19 101,970 $3.32 1,486,136 No 4 P Direct
Common Stock Acquisiton 2015-06-19 43,700 $3.32 710,366 No 4 P Indirect Owned by Birchview Fund LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect Owned by Birchview Fund LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants Acquisiton 2015-06-19 91,773 $0.13 91,773 $3.98
Common Stock Common Stock Warrants Acquisiton 2015-06-19 39,330 $0.13 39,330 $3.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
91,773 2015-06-29 2019-06-29 No 4 P Direct
39,330 2015-06-19 2019-06-19 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 66,664 Indirect Owned as custodian
Common Stock 14,949 Indirect By spouse as custodian UGMA for children
Common Stock 6,819 Indirect As trustee
Footnotes
  1. The reported securities are included in 101,970 units of Issuer securities (the "Units") purchased by the reporting person for $3.4325 per Unit pursuant to a Securities Purchase Agreement, dated June 15, 2015 (the "Securities Purchase Agreement") by and among the Issuer, the reporting person and certain other qualified institutional and individual investors. Each Unit consists of one share of the Issuer's Common Stock, par value $0.01 per share ("Common Stock") and and nine-tenths of a Common Stock warrant to purchase one share of Common Stock at an exercise price of $3.98 per share (subject to adjustment in the event of stock splits, stock dividends, reclassifications and the like).
  2. The reported securities are included in 43,700 Units purchased by Birchview Fund, LLC (the "Fund") for $3.4325 per Unit pursuant to the Securities Purchase Agreement. Mr. Strobeck is the sole member of Birchview Capital GP, LLC (the "GP"), the general partner of Birchview Capital, LP (the "Investment Manager"), which is the investment Manager of the Fund) and the sole member of Birchview Partners, LLC (the "Manager"), which is a member of the Fund. Mr. Strobeck disclaims Section 16 beneficial ownership of the shares of Common Stock held by the Fund (collectively, the "Fund Shares") and this report shall not be deemed an admission that such reporting person is the beneficial owner of such Fund Shares, except to the extent of his pecuniary interest, if any, in the Fund Shares by virtue of his membership interest in the GP.
  3. The shares of Common Stock reported herein give effect to the 1-for-6 reverse stock split which became effective in accordance with the terms of the Certificate of Amendment to the Company's Amended and Restated Certificate of Incorporation filed with the Secretary of State of Delaware on May 26, 2015.
  4. The reported securities are held in accounts for minor children for which the reporting person serves as a custodian. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  5. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  6. These shares are held indirectly by a trust for the benefit of the reporting person's children. The reporting person is a trustee of the trust. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest in them.